CoChat
Sign Up
Cited by 377

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Systemic Elevation of PTEN Induces a Tumor-Suppressive Metabolic State

Garcia-Cao, Isabel, Song, Min Sup, Hobbs, Robin M., Laurent, Gaelle, Giorgi, Carlotta, de Boer, Vincent C.J., Anastasiou, Dimitrios, Ito, Keisuke, Sasaki, Atsuo T., Rameh, Lucia, Carracedo, Arkaitz, Vander Heiden, Matthew G., Cantley, Lewis C., Pinton, Paolo, Haigis, Marcia C., Pandolfi, Pier Paolo·2012·Cell
DOI 10.1016/j.cell.2012.02.030PMC PMC3319228
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.cell.2012.02.030

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 66

  1. Alimonti, 2010, Subtle variations in Pten dose determine cancer susceptibility, Nat. Genet., 42, 454, 10.1038/ng.556 · DOI
  2. Altenberg, 2004, Genes of glycolysis are ubiquitously overexpressed in 24 cancer classes, Genomics, 84, 1014, 10.1016/j.ygeno.2004.08.010 · DOI
  3. Atsumi, 2002, High expression of inducible 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (iPFK-2; PFKFB3) in human cancers, Cancer Res., 62, 5881
  4. Banito, 2010, Induced pluripotent stem cells and senescence: learning the biology to improve the technology, EMBO Rep., 11, 353, 10.1038/embor.2010.47 · DOI
  5. Böhni, 1999, Autonomous control of cell and organ size by CHICO, a Drosophila homolog of vertebrate IRS1-4, Cell, 97, 865, 10.1016/S0092-8674(00)80799-0 · DOI
  6. Bonneau, 2000, Mutations of the human PTEN gene, Hum. Mutat., 16, 109, 10.1002/1098-1004(200008)16:2<109::AID-HUMU3>3.0.CO;2-0 · DOI
  7. Cantley, 1999, New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway, Proc. Natl. Acad. Sci. USA, 96, 4240, 10.1073/pnas.96.8.4240 · DOI
  8. Clower, 2010, The alternative splicing repressors hnRNP A1/A2 and PTB influence pyruvate kinase isoform expression and cell metabolism, Proc. Natl. Acad. Sci. USA, 107, 1894, 10.1073/pnas.0914845107 · DOI · Paper page
  9. Colombo, 2010, Anaphase-promoting complex/cyclosome-Cdh1 coordinates glycolysis and glutaminolysis with transition to S phase in human T lymphocytes, Proc. Natl. Acad. Sci. USA, 107, 18868, 10.1073/pnas.1012362107 · DOI
  10. David, 2010, HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer, Nature, 463, 364, 10.1038/nature08697 · DOI · Paper page
  11. Deberardinis, 2006, Phosphatidylinositol 3-kinase-dependent modulation of carnitine palmitoyltransferase 1A expression regulates lipid metabolism during hematopoietic cell growth, J. Biol. Chem., 281, 37372, 10.1074/jbc.M608372200 · DOI · Paper page
  12. DeBerardinis, 2008, The biology of cancer: metabolic reprogramming fuels cell growth and proliferation, Cell Metab., 7, 11, 10.1016/j.cmet.2007.10.002 · DOI · Paper page
  13. Di Cristofano, 1998, Pten is essential for embryonic development and tumour suppression, Nat. Genet., 19, 348, 10.1038/1235 · DOI
  14. Eng, 2003, PTEN: one gene, many syndromes, Hum. Mutat., 22, 183, 10.1002/humu.10257 · DOI
  15. Finck, 2006, Lipin 1 is an inducible amplifier of the hepatic PGC-1alpha/PPARalpha regulatory pathway, Cell Metab., 4, 199, 10.1016/j.cmet.2006.08.005 · DOI
  16. Gao, 2000, Drosophila PTEN regulates cell growth and proliferation through PI3K-dependent and -independent pathways, Dev. Biol., 221, 404, 10.1006/dbio.2000.9680 · DOI
  17. García-Cao, 2002, “Super p53” mice exhibit enhanced DNA damage response, are tumor resistant and age normally, EMBO J., 21, 6225, 10.1093/emboj/cdf595 · DOI · Paper page
  18. Gerhart-Hines, 2007, Metabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT1/PGC-1alpha, EMBO J., 26, 1913, 10.1038/sj.emboj.7601633 · DOI · Paper page
  19. Goberdhan, 1999, Drosophila tumor suppressor PTEN controls cell size and number by antagonizing the Chico/PI3-kinase signaling pathway, Genes Dev., 13, 3244, 10.1101/gad.13.24.3244 · DOI
  20. Gregory, 2003, Phosphorylation by glycogen synthase kinase-3 controls c-myc proteolysis and subnuclear localization, J. Biol. Chem., 278, 51606, 10.1074/jbc.M310722200 · DOI
  21. Griffiths, 2009, Mitochondrial calcium as a key regulator of mitochondrial ATP production in mammalian cells, Biochim. Biophys. Acta, 1787, 1324, 10.1016/j.bbabio.2009.01.019 · DOI
  22. Hatzivassiliou, 2005, ATP citrate lyase inhibition can suppress tumor cell growth, Cancer Cell, 8, 311, 10.1016/j.ccr.2005.09.008 · DOI · Paper page
  23. Huang, 1999, PTEN affects cell size, cell proliferation and apoptosis during Drosophila eye development, Development, 126, 5365, 10.1242/dev.126.23.5365 · DOI
  24. Hue, 1987, Role of fructose 2,6-bisphosphate in the control of glycolysis in mammalian tissues, Biochem. J., 245, 313, 10.1042/bj2450313 · DOI
  25. Johnston, 1999, Drosophila myc regulates cellular growth during development, Cell, 98, 779, 10.1016/S0092-8674(00)81512-3 · DOI
  26. Jones, 1996, An essential E box in the promoter of the gene encoding the mRNA cap-binding protein (eukaryotic initiation factor 4E) is a target for activation by c-myc, Mol. Cell. Biol., 16, 4754, 10.1128/MCB.16.9.4754 · DOI
  27. King, 2009, Glucose metabolism and programmed cell death: an evolutionary and mechanistic perspective, Curr. Opin. Cell Biol., 21, 885, 10.1016/j.ceb.2009.09.009 · DOI
  28. Leevers, 1999, Signalling through phosphoinositide 3-kinases: the lipids take centre stage, Curr. Opin. Cell Biol., 11, 219, 10.1016/S0955-0674(99)80029-5 · DOI
  29. Li, 2009, The Ink4/Arf locus is a barrier for iPS cell reprogramming, Nature, 460, 1136, 10.1038/nature08290 · DOI · Paper page
  30. Li, 2008, The adaptor protein of the anaphase promoting complex Cdh1 is essential in maintaining replicative lifespan and in learning and memory, Nat. Cell Biol., 10, 1083, 10.1038/ncb1768 · DOI
  31. Liu, 2010, CpG island hypermethylation of multiple tumor suppressor genes associated with loss of their protein expression during rat lung carcinogenesis induced by 3-methylcholanthrene and diethylnitrosamine, Biochem. Biophys. Res. Commun., 402, 507, 10.1016/j.bbrc.2010.10.061 · DOI
  32. Maehama, 1998, The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate, J. Biol. Chem., 273, 13375, 10.1074/jbc.273.22.13375 · DOI · Paper page
  33. Marroquin, 2007, Circumventing the Crabtree effect: replacing media glucose with galactose increases susceptibility of HepG2 cells to mitochondrial toxicants, Toxicol. Sci., 97, 539, 10.1093/toxsci/kfm052 · DOI
  34. Najafov, 2010, Uncoupling the Warburg effect from cancer, Proc. Natl. Acad. Sci. USA, 107, 19135, 10.1073/pnas.1014047107 · DOI
  35. Podsypanina, 1999, Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems, Proc. Natl. Acad. Sci. USA, 96, 1563, 10.1073/pnas.96.4.1563 · DOI
  36. Puigserver, 2003, Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator, Endocr. Rev., 24, 78, 10.1210/er.2002-0012 · DOI · Paper page
  37. Ravitz, 2007, c-myc Repression of TSC2 contributes to control of translation initiation and Myc-induced transformation, Cancer Res., 67, 11209, 10.1158/0008-5472.CAN-06-4351 · DOI
  38. Ruderman, 2001, Cell biology. Chewing the fat—ACC and energy balance, Science, 291, 2558, 10.1126/science.1060277 · DOI
  39. Salmena, 2008, Tenets of PTEN tumor suppression, Cell, 133, 403, 10.1016/j.cell.2008.04.013 · DOI
  40. Scanga, 2000, The conserved PI3′K/PTEN/Akt signaling pathway regulates both cell size and survival in Drosophila, Oncogene, 19, 3971, 10.1038/sj.onc.1203739 · DOI
  41. Sears, 2000, Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability, Genes Dev., 14, 2501, 10.1101/gad.836800 · DOI
  42. Simpson, 2001, PTEN: life as a tumor suppressor, Exp. Cell Res., 264, 29, 10.1006/excr.2000.5130 · DOI
  43. Song, 2011, Nuclear PTEN regulates the APC-CDH1 tumor-suppressive complex in a phosphatase-independent manner, Cell, 144, 187, 10.1016/j.cell.2010.12.020 · DOI
  44. Suzuki, 1998, High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice, Curr. Biol., 8, 1169, 10.1016/S0960-9822(07)00488-5 · DOI
  45. Tee, 2005, mTOR, translational control and human disease, Semin. Cell Dev. Biol., 16, 29, 10.1016/j.semcdb.2004.11.005 · DOI
  46. Telang, 2006, Ras transformation requires metabolic control by 6-phosphofructo-2-kinase, Oncogene, 25, 7225, 10.1038/sj.onc.1209709 · DOI
  47. Tennant, 2009, Metabolic transformation in cancer, Carcinogenesis, 30, 1269, 10.1093/carcin/bgp070 · DOI
  48. Tennant, 2010, Targeting metabolic transformation for cancer therapy, Nat. Rev. Cancer, 10, 267, 10.1038/nrc2817 · DOI
  49. Trotman, 2003, Pten dose dictates cancer progression in the prostate, PLoS Biol., 1, E59, 10.1371/journal.pbio.0000059 · DOI
  50. Trumpp, 2001, c-Myc regulates mammalian body size by controlling cell number but not cell size, Nature, 414, 768, 10.1038/414768a · DOI
  51. Utikal, 2009, Immortalization eliminates a roadblock during cellular reprogramming into iPS cells, Nature, 460, 1145, 10.1038/nature08285 · DOI
  52. Vander Heiden, 2010, Evidence for an alternative glycolytic pathway in rapidly proliferating cells, Science, 329, 1492, 10.1126/science.1188015 · DOI
  53. Verdu, 1999, Cell-autonomous regulation of cell and organ growth in Drosophila by Akt/PKB, Nat. Cell Biol., 1, 500, 10.1038/70293 · DOI
  54. Warburg, 1956, On the origin of cancer cells, Science, 123, 309, 10.1126/science.123.3191.309 · DOI · Paper page
  55. Weinkove, 1999, Regulation of imaginal disc cell size, cell number and organ size by Drosophila class I(A) phosphoinositide 3-kinase and its adaptor, Curr. Biol., 9, 1019, 10.1016/S0960-9822(99)80450-3 · DOI
  56. West, 1998, Translational induction of the c-myc oncogene via activation of the FRAP/TOR signalling pathway, Oncogene, 17, 769, 10.1038/sj.onc.1201990 · DOI
  57. Wexler, 1979, Pulmonary metastases from autochthonous 3-methylcholanthrene-induced murine tumors, J. Natl. Cancer Inst., 63, 1393
  58. Wu, 1999, Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1, Cell, 98, 115, 10.1016/S0092-8674(00)80611-X · DOI · Paper page
  59. Zhang, 2003, Loss of Tsc1/Tsc2 activates mTOR and disrupts PI3K-Akt signaling through downregulation of PDGFR, J. Clin. Invest., 112, 1223, 10.1172/JCI200317222 · DOI
  60. Graham, F.L., and van der Eb, A.J. (1973). A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52, 456–467. · DOI
  61. Jouaville, L.S., Pinton, P., Bastianutto, C., Rutter, G.A., and Rizzuto, R. (1999). Regulation of mitochondrial ATP synthesis by calcium: evidence for a long-term metabolic priming. Proc. Natl. Acad. Sci. USA 96, 13807–13812. · DOI
  62. Lin, J., Wu, P.H., Tarr, P.T., Lindenberg, K.S., St-Pierre, J., Zhang, C.Y., Mootha, V.K., Jäger, S., Vianna, C.R., Reznick, R.M., et al. (2004). Defects in adaptive energy metabolism with CNS-linked hyperactivity in PGC-1alpha null mice. Cell 119, 121–135. · DOI · Paper page
  63. Pinton, P., Rimessi, A., Romagnoli, A., Prandini, A., and Rizzuto, R. (2007). Biosensors for the detection of calcium and pH. Methods Cell Biol. 80, 297–325. · DOI
  64. Serunian, L.A., Auger, K.R., and Cantley, L.C. (1991). Identification and quantification of polyphosphoinositides produced in response to platelet-derived growth factor stimulation. Methods Enzymol. 198, 78–87. · DOI
  65. Todaro, G.J., and Green, H. (1963). Quantitative studies of the growth of mouse embryo cells in culture and their development into established lines. J. Cell Biol. 17, 299–313. · DOI
  66. Vander Heiden, M.G., Plas, D.R., Rathmell, J.C., Fox, C.J., Harris, M.H., and Thompson, C.B. (2001). Growth factors can influence cell growth and survival through effects on glucose metabolism. Mol. Cell. Biol. 21, 5899–5912. · DOI · Paper page

Cited by

Sorted by citations

See all 377

Metadata

Authors
Garcia-Cao, I., Song, M. S., Hobbs, R. M., Laurent, G., Giorgi, C., de Boer, V. C. J., Anastasiou, D., Ito, K., Sasaki, A. T., Rameh, L., Carracedo, A., Vander Heiden, M. G., Cantley, L. C., Pinton, P., Haigis, M. C., & Pandolfi, P. P.
Venue
Cell
Publisher
Elsevier BV
Published
2012-03
Volume
149
Issue
1
Pages
49-62
ISSN
0092-8674
DOI
10.1016/j.cell.2012.02.030
PMC
PMC3319228
Cited by
377
References
15
Language
en
Licence
Funders
  • Ministerio de Educación, Cultura y Deporte
  • Associazione Italiana per la Ricerca sul Cancro
  • National Institutes of Health (P01-CA089021, R01 CA-82328-09, R01-GM41890)
  • Human Frontier Science Program

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review